C5AR1 and systemic lupus erythematosus: This immunoregulatory pathway is disrupted in the SLE case and other IFN-I-dominated autoinflammatory conditions, where the chronic activation of C5a will suppress the IFN-I induction of IL-27 production and permit the generation of pathogenic Th17 cells.